NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Studies of the Natural History of Rheumatic Disease in Minority Communities

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

01-AR-0227

Sponsoring Institute

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 18
Max Age: N/A

Referral Letter Required

No

Population Exclusion(s)

Children

Special Instructions

Currently Not Provided

Keywords

Minorities;
Rheumatic Disease;
Community Based

Recruitment Keyword(s)

Rheumatic Disease;
Ethnicity;
Health Disparities

Condition(s)

Rheumatic Disease

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Institute of Arthritis and Musculoskeletal and Skin Diseases

This study will explore the causes of rheumatic diseases and why many of them affect certain minority communities more severely. Rheumatic diseases may cause joint pain, stiffness or swelling. Some can involve bones, muscles, tendons or ligaments. Some cause abnormalities of the immune system the body s defense against disease. Some rheumatic diseases are painful or deforming and some can be life threatening. Information obtained from this study will be used to learn about the disparities in rheumatic disease in the minority community and to design further, more targeted, research studies to address this issue.

Patients with known or suspected rheumatic disease 18 years of age or older may be eligible for this study. Candidates will undergo a medical history and physical examination to confirm the diagnosis of rheumatic disease and determine what is needed for evaluation and treatment.

Participants will receive standard medical care for rheumatic disease and arthritis. No experimental treatments, medications or procedures will be included in this study. Procedures may include routine blood tests for blood chemistries, cell counts, and antibodies commonly found in patients with rheumatic disease; a urine test for proteins and cells; and X-rays and other imaging tests to check for abnormalities in the lungs or other organs. All medical information will be kept confidential.

Patients who are found to be eligible for other current NIH research studies will be offered an opportunity to participate in these studies.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Subjects with known or suspected rheumatic disease.

Age greater than or equal to 18 years.

Willingness and capacity to provide informed consent.

EXCLUSION CRITERIA:

Patients who cannot meet the inclusion criteria.


--Back to Top--

Citations:

Systemic lupus erythematosus in three ethnic groups: I The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset LUMINA Study Group Lupus in minority populations, nature versus nurture

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

Effect of race and ethnicity on outcomes in arthritis and rheumatic conditions

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

James D. Katz, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
BG 10 RM 6N216F
10 CENTER DR
BETHESDA MD 20814
(301) 451-6807
james.katz@nih.gov

James D. Katz, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
BG 10 RM 6N216F
10 CENTER DR
BETHESDA MD 20814
(301) 451-6807
james.katz@nih.gov

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: 1-866-411-1010
PRPL@cc.nih.gov

Clinical Trials Number:

NCT00024479

--Back to Top--